NCT00016146View on ClinicalTrials.gov

Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

GPI-0100

BIOLOGICAL

MUC-2-Globo H-KLH conjugate vaccine

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00016146 - Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter